---
title: "SAPIRSTEIN JAMES — Ownership Dossier"
canonical: https://whiteintel.dev/entity/487555e2-51af-54b5-825e-d8ed110fc76b
json: https://whiteintel.dev/api/public/dossier/487555e2-51af-54b5-825e-d8ed110fc76b
identifier: sec:0001559509
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SAPIRSTEIN JAMES

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001559509`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/487555e2-51af-54b5-825e-d8ed110fc76b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/487555e2-51af-54b5-825e-d8ed110fc76b  

## Ownership & control

### Holdings / subsidiaries

- **BIOZONE PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/c1efff2d-6a3c-5b1c-b7c4-abe2a8935582
- **LARKSPUR HEALTH ACQUISITION CORP.** (director) — https://whiteintel.dev/entity/83d3fe69-d675-5239-b9c0-5c404b4ec0c5
- **Onconetix, Inc.** (director) — https://whiteintel.dev/entity/c87d2f29-ac86-57dd-8f50-dc7bb0647519
- **Entero Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/693ec0f7-88c9-5d8e-84ba-59ed6771b65c
- **Entero Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/693ec0f7-88c9-5d8e-84ba-59ed6771b65c
- **RENOVARO INC.** (director) — https://whiteintel.dev/entity/e2cf457c-f8c6-5ea8-933d-457fcccc2c24
- **GBS ENTERPRISES INC** (director) — https://whiteintel.dev/entity/7f01b0d1-ec87-5a35-b376-4acf48c0872f
- **GBS ENTERPRISES INC** (officer) — https://whiteintel.dev/entity/7f01b0d1-ec87-5a35-b376-4acf48c0872f
- **BLUE WATER ACQUISITION CORP.** (director) — https://whiteintel.dev/entity/b5f0877c-4dcf-5a3c-961f-d33a4fc6ba13
- **GBS ENTERPRISES INC** (officerother) — https://whiteintel.dev/entity/7f01b0d1-ec87-5a35-b376-4acf48c0872f
- **CONTRAVIR PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/9d4a1382-097f-50bd-bbb5-a06a1195a958
- **CONTRAVIR PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/9d4a1382-097f-50bd-bbb5-a06a1195a958
- **CORTEX PHARMACEUTICALS INC/DE/** (director) — https://whiteintel.dev/entity/36d1f1dd-be8e-51f5-94bf-f2a8cfe78b55
- **NEF ENTERPRISES, INC.** (director) — https://whiteintel.dev/entity/bdd34f08-7abf-5a52-a93d-cdca4e6c0e23
- **ADYNXX, INC.** (officer) — https://whiteintel.dev/entity/70ac12b9-27d7-5580-9d96-f2dd457f7e80
- **ADYNXX, INC.** (director) — https://whiteintel.dev/entity/70ac12b9-27d7-5580-9d96-f2dd457f7e80

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SAPIRSTEIN JAMES**. Human view: https://whiteintel.dev/entity/487555e2-51af-54b5-825e-d8ed110fc76b · Structured JSON: https://whiteintel.dev/api/public/dossier/487555e2-51af-54b5-825e-d8ed110fc76b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._